The unequal distribution of COVID-19 vaccines has left 80 percent of global vaccine stocks in the hands of just 10 countries.
This situation was exacerbated by the administration of former US president Donald Trump, which last year attempted to withdraw from the WHO.
This opened a political vacuum that China immediately filled, allowing Beijing to engage in “vaccine diplomacy,” enhance its soft power and promote Chinese President Xi Jinping’s (習近平) vision of a Chinese “community of shared human destiny.”
Beijing used its vaccine diplomacy to project China as an ethical force for good, as opposed to “selfish” Western nations, which stockpiled vaccines for themselves. The Chinese Communist Party sought to build a narrative that China was working to provide every country access to COVID-19 vaccines, as a public commodity.
Using this message, Beijing was able to shift attention toward production capacity and distribution, and away from the efficacy of the vaccines in inoculating people against the disease.
Is China really more benevolent than Western nations?
According to US research, China only donated a small quantity of vaccines to specific markets or nations for trial purposes. Most Chinese vaccines were sold, not donated, to foreign nations.
A research paper published by Springer Nature titled “Vaccine diplomacy: nation branding and China’s COVID-19 soft power play” shows that of the 656 million doses of COVID-19 vaccine Chinese pharmaceutical companies exported to foreign nations at the time of the study, only 8.6 million, or 1.31 percent, were donated; the rest were sold.
Moreover, most sales have been concentrated in Latin American, Southeast Asian and African nations. Since most of these countries lack robust cold chain storage technology, China’s inactivated virus vaccines were more attractive than Western messenger ribonucleic acid — known as mRNA — vaccines, since inactivated virus vaccines are easier to store, requiring only conventional refrigeration.
Sinovac’s CoronaVac vaccine retails for US$13.60 per shot, while the most expensive of China’s COVID-19 vaccines sell for US$60 per shot. Compared with US$4 per shot for the AstraZeneca vaccine, China’s offerings are considerably more expensive.
For simplicity, if China sold the CoronaVac vaccine at US$13.60 per shot, it made US$8.8 billion from export sales through this one vaccine.
While other countries have donated vaccines to the COVAX scheme, China has sold its vaccines to the program. Beijing has also provided economically weak nations with loans to purchase its vaccines, using every available opportunity to make money from the crisis.
China is quietly lining its pockets, yet has the temerity to criticize Western nations and cast itself as the savior of the world.
Yang Chun-chieh is a graduate student at National Tsing-Hua University’s Institute of Sociology.
Translated by Edward Jones
US aerospace company Boeing Co has in recent years been involved in numerous safety incidents, including crashes of its 737 Max airliners, which have caused widespread concern about the company’s safety record. It has recently come to light that titanium jet engine parts used by Boeing and its European competitor Airbus SE were sold with falsified documentation. The source of the titanium used in these parts has been traced back to an unknown Chinese company. It is clear that China is trying to sneak questionable titanium materials into the supply chain and use any ensuing problems as an opportunity to
It’s not every month that the US Department of State sends two deputy assistant secretary-level officials to Taiwan, together. Its rarer still that such senior State Department policy officers, once on the ground in Taipei, make a point of huddling with fellow diplomats from “like-minded” NATO, ANZUS and Japanese governments to coordinate their multilateral Taiwan policies. The State Department issued a press release on June 22 admitting that the two American “representatives” had “hosted consultations in Taipei” with their counterparts from the “Taiwan Ministry of Foreign Affairs.” The consultations were blandly dubbed the “US-Taiwan Working Group on International Organizations.” The State
The Chinese Supreme People’s Court and other government agencies released new legal guidelines criminalizing “Taiwan independence diehard separatists.” While mostly symbolic — the People’s Republic of China (PRC) has never had jurisdiction over Taiwan — Tamkang University Graduate Institute of China Studies associate professor Chang Wu-ueh (張五岳), an expert on cross-strait relations, said: “They aim to explain domestically how they are countering ‘Taiwan independence,’ they aim to declare internationally their claimed jurisdiction over Taiwan and they aim to deter Taiwanese.” Analysts do not know for sure why Beijing is propagating these guidelines now. Under Chinese President Xi Jinping (習近平), deciphering the
Delegation-level visits between the two countries have become an integral part of transformed relations between India and the US. Therefore, the visit by a bipartisan group of seven US lawmakers, led by US House of Representatives Committee on Foreign Affairs Chairman Michael McCaul to India from June 16 to Thursday last week would have largely gone unnoticed in India and abroad. However, the US delegation’s four-day visit to India assumed huge importance this time, because of the meeting between the US lawmakers and the Dalai Lama. This in turn brings us to the focal question: How and to what extent